The Wegovy tablet has already launched in the United States, where it received FDA approval in December 2025 and became available from January 2026
Branched fibers from old fast-twitch dystrophic muscles are the sites of terminal damage in muscular dystrophy
Protein supplementation during GLP-1 treatment can further support muscle preservation
If recent lab work is not available, we may order a baseline panel before proceeding
doi: 10.3389/fimmu.2025.1698832 Received 04 September 2025 Revised 03 November 2025 Accepted 13 November 2025 Published 02 December 2025 Volume 16 - 2025 Edited by Fernanda Degobbi Tenorio Quirino dos Santos Lopes, University of So Paulo, Brazil Reviewed by Franziska Roth-Walter, University of Veterinary Medicine Vienna, Austria Thayse Bruggemann, Brigham and Womens Hospital and Harvard Medical School, United States Updates Copyright 2025 Zeng, Zhang, Li, Li, Li, Xie, Zhang, Xie and Yang
Semaglutide is *not* a vitamin, mineral or amino acid